Use of Neuromelanin-Sensitive MRI to Distinguish Schizophrenic and Depressive Patients and Healthy Individuals Based on Signal Alterations in the Substantia Nigra and Locus Ceruleus

Biological Psychiatry

Volumn 64, Issue 5, 2008, Pages 401-406

  Shibata, Eri ^a   Sasaki, Makoto ^a   Tohyama, Koujiro ^a   Otsuka, Kotaro ^a   Endoh, Jin ^a   Terayama, Yasuo ^a   Sakai, Akio ^a  

^a IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Depression; locus ceruleus; magnetic resonance imaging; neuromelanin; schizophrenia; substantia nigra

Indexed keywords

NEUROMELANIN;

ADULT; APPARATUS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DIFFUSION WEIGHTED IMAGING; FEMALE; HUMAN; IMAGE ANALYSIS; LOCUS CERULEUS; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; SIGNAL DETECTION; SUBSTANTIA NIGRA;

ADULT; ANALYSIS OF VARIANCE; CASE-CONTROL STUDIES; DEPRESSION; FEMALE; HUMANS; LOCUS COERULEUS; MAGNETIC RESONANCE IMAGING; MALE; MELANINS; MIDDLE AGED; PROSPECTIVE STUDIES; SCHIZOPHRENIA; STATISTICS, NONPARAMETRIC; SUBSTANTIA NIGRA;

EID: 48749125094     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2008.03.021     Document Type: Article

References (27)

1. Mackay A.V., Iversen L.L., Rossor M., Spokes E., Bird E., Arregui A., et al. Increased brain dopamine and dopamine receptors in schizophrenia. Arch Gen Psychiatry 39 (1982) 991-997
2. Moore H., West A.R., and Grace A.A. The regulation of forebrain dopamine transmission: Relevance to the pathophysiology and psychopathology of schizophrenia. Biol Psychiatry 46 (1999) 40-55
3. Siever L.J., and Davis K.L. Overview: Toward a dysregulation hypothesis of depression. Am J Psychiatry 142 (1985) 1017-1031
4. Malhi G.S., Parker G.B., and Greenwood J. Structural and functional models of depression; from sub-types to substrates. Acta Psychiatr Scand 11 (2005) 94-105
5. Martinot J.L., Peron-Magnan P., Huret J.D., Mazoyer B., Baron J.C., Boulenger J.P., et al. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients. Am J Psychiatry 147 (1990) 44-50
6. Farde L., Wiesel F.A., Stone-Elander S., Halldin C., Nordstrom A.L., Hall H., et al. D2 dopamine receptors in neuroleptic-naive schizophrenic patients. A positron emission tomography study with [11C]raclopride. Arch Gen Psychiatry 47 (1990) 213-219
7. Hietala J., Syvalahti E., Vuorio K., Nagren K., Lehikoinen P., Ruotsalainen U., et al. Striatal D2 dopamine receptor characteristics in neuroleptic-naive schizophrenic patients studied with positron emission tomography. Arch Gen Psychiatry 51 (1994) 116-123
8. Okubo Y., Suhara T., Suzuki K., Kobayashi K., Inoue O., Terasaki O., et al. Decreased prefrontal dopamine D1 receptors in schizophrenia revealed by PET. Nature 385 (1997) 634-636
9. Graham D.G. On the origin and significance of neuromelanin. Arch Pathol Lab Med 103 (1979) 359-362
10. Sasaki M., Shibata E., Tohyama K., Takahashi J., Otsuka K., Tsuchiya K., et al. Neuromelanin magnetic resonance imaging of locus ceruleus and substantia nigra in Parkinson's disease. Neuroreport 31 (2006) 1215-1218
11. Shibata E., Sasaki M., Tohyama K., Otsuka K., and Sakai A. Reduced signal of locus ceruleus in depression in quantitative neuromelanin magnetic resonance imaging. Neuroreport 18 (2007) 415-418
12. German D.C., Walker B.S., Manaye K., Smith W.K., Woodward D.J., and North A.J. The human locus coeruleus: Computer reconstruction of cellular distribution. J Neurosci 8 (1988) 193-203
13. Van Woert M.H., and Ambani L.M. Biochemistry of neuromelanin. Adv Neurol 5 (1974) 215-223
14. Enochs W.S., Petherick P., Bogdanova A., Mohr U., and Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204 (1997) 417-423
15. Tosk J.M., Holshouser B.A., Aloia R.C., Hinshaw D.B., Hasso A.N., MacMurray J.P., et al. Effects of the interaction between ferric iron and L-dopa melanin on T1 and T2 relaxation times determined by magnetic resonance imaging. Magn Reson Med 26 (1992) 40-45
16. Wansapura J.P., Holland S.K., Dunn R.S., and Ball W.S. NMR relaxation times in the human brain at 3.0 tesla. J Magn Reson Imaging 9 (1999) 531-538
17. Melki P.S., and Mulkern R.V. Magnetization transfer effects in multislice RARE sequences. Magn Reson Med 24 (1992) 189-195
18. Shibata E., Sasaki M., Tohyama K., Kanbara Y., Otsuka K., Ehara S., et al. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla. Magn Reson Med Sci 5 (2006) 197-200
19. Kaiya H. Neuromelanin, neuroleptics and schizophrenia: Hypothesis of an interaction between noradrenergic and dopaminergic system. Neuropsychobiology 6 (1980) 241-248
20. Craven R.M., Priddle T.H., Crow T.J., and Esiri M.M. The locus coeruleus in schizophrenia: a postmortem study of noradrenergic neurons. Neuropathol Appl Neurobiol 31 (2005) 115-126
21. Lohr J.B., and Jeste D.V. Locus ceruleus morphometry in aging and schizophrenia. Acta Psychiatr Scand 77 (1988) 689-697
22. Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry 44 (1987) 660-669
23. Baumann B., Danos P., Krell D., Diekmann S., Wurthmann C., Bielau H., et al. Unipolar-bipolar dichotomy of mood disorders is supported by noradrenergic brainstem system morphology. J Affect Disord 54 (1999) 217-224
24. Friedman A., Dremencov E., Crown H., Levy D., Mintz M., Overstreet D.H., et al. Variability of the mesolimbic neuronal activity in a rat model of depression. Neuroreport 16 (2005) 513-516
25. Tung C.S., Ugedo L., Grenhoff J., Engberg G., and Svensson T.H. Peripheral induction of burst firing in locus coeruleus neurons by nicotine mediated via excitatory amino acids. Synapse 4 (1989) 313-318
26. Enochs W.S., Petherick P., Bogdanova A., Mohr U., and Weissleder R. Paramagnetic metal scavenging by melanin: MR imaging. Radiology 204 (1997) 417-423
27. Casanova M.F., Comparini S.O., Kim R.W., and Kleinman J.E. Staining intensity of brain iron in patients with schizophrenia: A postmortem study. J Neuropsychiatry Clin Neurosci 4 (1992) 36-41